Page 1

INTERIM REPORT JULY - SEPTEMBER 2021 Third quarter Revenue amounted to € 335.0m ( € 262.5m ) , an increase of 27.6 % with an organic growth of 23.9 % . ● ● ● Operating profit ( EBIT ) was € 30.0m ( € 27.3m ) , representing an operating margin of 9.0 % ( 10.4 % ) . Net profit amounted to € 18.4m ( € 19.5m ) , which represents a net profit margin of 5.5 % ( 7.5 % ) . MEDICOVER EBITDA was € 58.0m ( € 50.1m ) , an increase by 15.7 % . EBITDA margin was 17.3 % ( 19.1 % ) . EBITDAAL amounted to € 42.8m ( € 38.1m ) , corresponding to an EBITDAAL margin of 12.8 % ( 14.5 % ) . Net cash flow from operating activities was € 67.0m ( € 41.2m ) . Basic / diluted earnings per share were € 0.123 ( € 0.108 ) . REVENUE AND EARNINGS € millions ( € m ) Revenue Operating profit ( EBIT ) Operating profit margin Net profit Net profit margin Basic / diluted earnings per share , € EBITDA EBITDA margin EBITDAAL EBITDAAL margin Q3 2021 Q3 2020 335.0 262.5 30.0 27.3 9.0 % 10.4 % 18.4 5.5 % 0.123 19.5 7.5 % 0.108 Nine months ● Revenue amounted to € 1,001.1m ( € 700.1m ) , an increase of 43.0 % with an organic growth of 44.1 % . ● ● ● Operating profit ( EBIT ) was € 117.8m ( € 31.4m ) , representing an operating margin of 11.8 % ( 4.5 % ) . Net profit amounted to € 78.2m ( € 8.5m ) , which represents a net profit margin of 7.8 % ( 1.2 % ) . EBITDA was € 195.3m ( € 104.4m ) , an increase by 87.0 % . EBITDA margin was 19.5 % ( 14.9 % ) . EBITDAAL amounted to € 153.9m ( € 67.3m ) , corresponding to an EBITDAAL margin of 15.4 % ( 9.6 % ) . Net cash flow from operating activities was € 162.8m ( € 116.1m ) . Basic / diluted earnings per share were € 0.501 ( € 0.054 ) . Growth 28 % 1,001.1 10 % 117.8 11.8 % 78.2 7.8 % -6 % 14 % 16 % 9M 2021 9M 2020 Growth 700.1 31.4 4.5 % 12 % 8 % 0.501 58.0 50.1 104.4 17.3 % 19.1 % 14.9 % 42.8 38.1 67.3 12.8 % 14.5 % 9.6 % EBITA 32.6 30.1 44.2 9.7 % 11.5 % 6.3 % EBITA margin Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information . 8.5 1.2 % 195.3 19.5 % 153.9 15.4 % 125.3 12.5 % 0.054 43 % 275 % 819 % 828 % 87 % 129 % 183 % FY 2020 997.8 61.3 6.1 % 27.3 2.7 % 0.182 157.5 15.8 % 108.5 10.9 % 76.9 7.7 % Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics , hospitals , specialty - care facilities , laboratories and blood - drawing points and the largest markets are Poland and Germany . 2020 , Medicover had revenue of € 998 million and more than 32,000 employees . For more information , go to www.medicover.com Medicover AB ( Publ ) | P.O. Box 5283 | SE - 102 46 Stockholm | Visiting address : Riddargatan 12A | Sweden 1